TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
TPTX
Delisted
TPTX was delisted on the 16th of August, 2022.
70 hedge funds and large institutions have $742M invested in Turning Point Therapeutics, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 69 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
70
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
1 | +$127M | |
2 | +$121M | |
3 | +$104M | |
4 |
FCMI
Foresite Capital Management IV
Larkspur,
California
|
+$74.5M |
5 |
VP
venBio Partners
San Francisco,
California
|
+$54.5M |
Top Sellers
No sellers this quarter